Effects of Oral and Intravenous Administration of Buspirone on Food–Cocaine Choice in Socially Housed Male Cynomolgus Monkeys

Drugs acting at D3 dopamine receptors have been suggested as medications for cocaine dependence. These experiments examined the effects of intravenously and orally administered buspirone, a D2-like receptor antagonist with high affinity for D3 and D4 receptors, on the relative reinforcing strength of cocaine in group-housed male cynomolgus monkeys. Use of socially housed monkeys permitted the assessment of whether social status, known to influence D2-like receptor availability, modulates the behavioral effects of buspirone. Buspirone was administered acutely to monkeys self-administering cocaine under a food–drug choice procedure in which a cocaine self-administration dose–effect curve was determined daily. When administered by either route, buspirone significantly decreased cocaine choice in dominant-ranked monkeys. In subordinate monkeys, however, i.v. buspirone was ineffective on average, and oral buspirone increased choice of lower cocaine doses. The effects of buspirone only differed according to route of administration in subordinate monkeys. Moreover, it is noteworthy that the effects of buspirone were similar to those of the D3 receptor-selective antagonist PG01037 and qualitatively different than those of less selective drugs that act at D2-like or serotonin (5-HT)1A receptors, suggesting a D3 and possibly D4 receptor mechanism of action for buspirone. Taken together, the data support the utility of drugs targeting D3/D4 receptors as potential treatments for cocaine addiction, particularly in combination with enriching environmental manipulations.

[1]  G. Curzon Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding. , 1991, Advances in experimental medicine and biology.

[2]  Gregory S. Brigham,et al.  Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. , 2014, The Journal of clinical psychiatry.

[3]  D. Mash,et al.  Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities , 1996, The Journal of Neuroscience.

[4]  F. Gawin Neuroleptic reduction of cocaine-induced paranoia but not euphoria? , 2004, Psychopharmacology.

[5]  M. Nader,et al.  Relationship Between Social Rank and Cortisol and Testosterone Concentrations in Male Cynomolgus Monkeys (Macaca fascicularis) , 2009, Journal of neuroendocrinology.

[6]  M. Nader,et al.  PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. , 2005, The American journal of psychiatry.

[7]  E. London,et al.  Dopamine D3 receptors as a therapeutic target for methamphetamine dependence , 2014, The American journal of drug and alcohol abuse.

[8]  G. Sedvall,et al.  Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.

[9]  J. Shearer,et al.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. , 2004, Addictive behaviors.

[10]  J. Kebabian,et al.  S-(+)-aporphines are not selective for human D3 dopamine receptors , 1994, Cellular and Molecular Neurobiology.

[11]  D. Sibley,et al.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. , 2013, The international journal of neuropsychopharmacology.

[12]  T. Barnes Antipsychotic Drugs and their Side-Effects , 1993 .

[13]  S. B. Caine,et al.  Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. , 2000, Experimental and clinical psychopharmacology.

[14]  N. Mello,et al.  Effects of dopamine D1-like and D2-like agonists in rats trained to discriminate cocaine from saline: influence of experimental history. , 2000 .

[15]  W. Woolverton,et al.  Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. , 1981, Drug and alcohol dependence.

[16]  Michael A. Nader,et al.  Individual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomolgus monkeys , 2011, Psychopharmacology.

[17]  C. Heidbreder Rationale in support of the use of selective dopamine D3 receptor antagonists for the pharmacotherapeutic management of substance use disorders , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  N. Volkow,et al.  Therapeutic doses of buspirone block D3 receptors in the living primate brain. , 2014, The international journal of neuropsychopharmacology.

[19]  D. Sibley,et al.  Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. , 2012, Biochemical pharmacology.

[20]  K. Cunningham,et al.  Dopamine D1 and D2 mediation of the discriminative stimulus properties ofd-amphetamine and cocaine , 2005, Psychopharmacology.

[21]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[22]  M. Nader,et al.  The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys , 2006, Pharmacology Biochemistry and Behavior.

[23]  N. Mello,et al.  Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration , 2013, Neuropsychopharmacology.

[24]  P. W. Czoty,et al.  Effects of the 5-HT1A agonist (±)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on cocaine choice in cynomolgus monkeys , 2005, Behavioural pharmacology.

[25]  J. Ginos,et al.  Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. , 1984, The Journal of pharmacology and experimental therapeutics.

[26]  Rainer Enkelmann Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder , 2005, Psychopharmacology.

[27]  M. Nader,et al.  Nonhuman primate models of social behavior and cocaine abuse , 2012, Psychopharmacology.

[28]  L. E. Thomson,et al.  Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case study. , 1997, Journal of substance abuse treatment.

[29]  T. Barnes,et al.  THE SIDE-EFFECTS OF ANTIPSYCHOTIC DRUGS. I. CNS AND NEUROMUSCULAR EFFECTS , 1993 .

[30]  J. Schmitz,et al.  Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. , 2009, Drug and alcohol dependence.

[31]  M. Bardo,et al.  Individual Differences and Social Influences on the Neurobehavioral Pharmacology of Abused Drugs , 2013, Pharmacological Reviews.

[32]  David R. Sibley,et al.  Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes , 1999, Neuropsychopharmacology.

[33]  R. Croop,et al.  Pharmacokinetics of a Newly Identified Active Metabolite of Buspirone After Administration of Buspirone Over Its Therapeutic Dose Range , 2006, Journal of clinical pharmacology.

[34]  A. Fink-Jensen,et al.  Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats , 2008, Psychopharmacology.

[35]  S. Peroutka Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors , 1985, Biological Psychiatry.

[36]  R. Taub,et al.  6-Hydroxybuspirone Is a Major Active Metabolite of Buspirone: Assessment of Pharmacokinetics and 5-Hydroxytryptamine1A Receptor Occupancy in Rats , 2007, Drug Metabolism and Disposition.

[37]  S. B. Caine,et al.  Role of Dopamine D2-like Receptors in Cocaine Self-Administration: Studies with D2 Receptor Mutant Mice and Novel D2 Receptor Antagonists , 2002, The Journal of Neuroscience.

[38]  L. Amato,et al.  Dopamine agonists for the treatment of cocaine dependence. , 2011, The Cochrane database of systematic reviews.

[39]  M. Nader,et al.  Effects of Dopamine D2/D3 Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[40]  R. De La Garza,et al.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. , 2012, Pharmacology & therapeutics.

[41]  N. Mello,et al.  Effects of Chronic Buspirone Treatment on Cocaine Self-Administration , 2013, Neuropsychopharmacology.

[42]  M. Nader,et al.  Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm , 2014, Psychopharmacology.

[43]  M. Mohammadi,et al.  Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study. , 2012, Acta medica Iranica.

[44]  S. Manuck,et al.  Social Status, Environment, and Atherosclerosisin Cynomolgus Monkeys , 1982, Arteriosclerosis.

[45]  M. Nader,et al.  Effects of Two Novel D3-Selective Compounds, NGB 2904 [N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide], on the Reinforcing and Discriminative Stimulus Effects of Cocaine in Rhesus M , 2007, Journal of Pharmacology and Experimental Therapeutics.

[46]  Sylvain Houle,et al.  Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. , 2005, Journal of medicinal chemistry.

[47]  K. Brady,et al.  Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. , 2012, Contemporary clinical trials.

[48]  Paul A Keller,et al.  Control of hepatitis C: a medicinal chemistry perspective. , 2005, Journal of medicinal chemistry.

[49]  M. Nader,et al.  Assessment of the Relative Reinforcing Strength of Cocaine in Socially Housed Monkeys Using a Choice Procedure , 2005, Journal of Pharmacology and Experimental Therapeutics.

[50]  M. Nader,et al.  Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine , 2010, Psychopharmacology.

[51]  Z. Xi,et al.  PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats , 2011, Journal of psychopharmacology.

[52]  A. Newman,et al.  Cocaine self-administration in dopamine D₃ receptor knockout mice. , 2012, Experimental and clinical psychopharmacology.

[53]  L. Gold,et al.  Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys , 2005, Psychopharmacology.

[54]  M. Nader,et al.  Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration , 2002, Nature Neuroscience.

[55]  M. Nader,et al.  Social Dominance in Female Monkeys: Dopamine Receptor Function and Cocaine Reinforcement , 2012, Biological Psychiatry.

[56]  A. Newman,et al.  Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders , 2010, Annals of the New York Academy of Sciences.

[57]  M. Banks,et al.  Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration , 2012, Advances in pharmacological sciences.

[58]  M. Nader,et al.  Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents. , 2005, Journal of medicinal chemistry.

[59]  A. Stotts,et al.  Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. , 2000, Journal of clinical psychopharmacology.

[60]  J. Tallman,et al.  I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[61]  Ji-Kyung Choi,et al.  Heterocyclic analogues of N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands: potential substance abuse therapeutic agents. , 2007, Journal of medicinal chemistry.

[62]  S. Negus Rapid Assessment of Choice between Cocaine and Food in Rhesus Monkeys: Effects of Environmental Manipulations and Treatment with d-Amphetamine and Flupenthixol , 2003, Neuropsychopharmacology.

[63]  Sylvain Houle,et al.  Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO , 2014, Neuropsychopharmacology.